157 related articles for article (PubMed ID: 11781234)
1. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.
Stearns-Kurosawa DJ; Swindle K; D'Angelo A; Della Valle P; Fattorini A; Caron N; Grimaux M; Woodhams B; Kurosawa S
Blood; 2002 Jan; 99(2):526-30. PubMed ID: 11781234
[TBL] [Abstract][Full Text] [Related]
2. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.
Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A
Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
[TBL] [Abstract][Full Text] [Related]
4. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
5. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
6. Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.
Ducros E; Mirshahi SS; Faussat AM; Mirshahi P; Dimicoli S; Tang R; Pardo J; Ibrahim J; Marie JP; Therwath A; Soria J; Mirshahi M
Cancer Med; 2012 Oct; 1(2):261-7. PubMed ID: 23342274
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function.
Liaw PC; Neuenschwander PF; Smirnov MD; Esmon CT
J Biol Chem; 2000 Feb; 275(8):5447-52. PubMed ID: 10681521
[TBL] [Abstract][Full Text] [Related]
8. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
Uitte de Willige S; Van Marion V; Rosendaal FR; Vos HL; de Visser MC; Bertina RM
J Thromb Haemost; 2004 Aug; 2(8):1305-10. PubMed ID: 15304035
[TBL] [Abstract][Full Text] [Related]
9. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Holm J; Hillarp A; Erhardt L; Berntorp E
Thromb Res; 1999 Nov; 96(3):205-12. PubMed ID: 10588463
[TBL] [Abstract][Full Text] [Related]
10. Identification of functional endothelial protein C receptor in human plasma.
Kurosawa S; Stearns-Kurosawa DJ; Hidari N; Esmon CT
J Clin Invest; 1997 Jul; 100(2):411-8. PubMed ID: 9218519
[TBL] [Abstract][Full Text] [Related]
11. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.
Jerkeman A; Astermark J; Hedner U; Lethagen S; Olsson CG; Berntorp E
Thromb Res; 2000 Jun; 98(6):467-71. PubMed ID: 10899345
[TBL] [Abstract][Full Text] [Related]
12. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor.
Fukudome K; Ye X; Tsuneyoshi N; Tokunaga O; Sugawara K; Mizokami H; Kimoto M
J Exp Med; 1998 Apr; 187(7):1029-35. PubMed ID: 9529319
[TBL] [Abstract][Full Text] [Related]
13. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
Ireland H; Konstantoulas CJ; Cooper JA; Hawe E; Humphries SE; Mather H; Goodall AH; Hogwood J; Juhan-Vague I; Yudkin JS; di Minno G; Margaglione M; Hamsten A; Miller GJ; Bauer KA; Kim YT; Stearns-Kurosawa DJ; Kurosawa S
Atherosclerosis; 2005 Dec; 183(2):283-92. PubMed ID: 15921688
[TBL] [Abstract][Full Text] [Related]
14. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
15. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
Zeuthen EL; Lassen JF; Husted SE
Thromb Res; 2003 Mar; 109(5-6):241-6. PubMed ID: 12818245
[TBL] [Abstract][Full Text] [Related]
16. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?
Saposnik B; Peynaud-Debayle E; Stepanian A; Baron G; Simansour M; Mandelbrot L; de Prost D; Gandrille S
Thromb Res; 2012 Feb; 129(2):152-7. PubMed ID: 21824644
[TBL] [Abstract][Full Text] [Related]
17. Effect of cardiopulmonary bypass on thrombin generation and protein C pathway.
Taneja R; Liaw PL; Al Ghazaly S; Priestap F; Murkin JM; Martin CM
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):35-40. PubMed ID: 23312776
[TBL] [Abstract][Full Text] [Related]
18. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
19. Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis.
Guitton C; Gérard N; Sébille V; Bretonnière C; Zambon O; Villers D; Charreau B
Intensive Care Med; 2011 Jun; 37(6):950-6. PubMed ID: 21394629
[TBL] [Abstract][Full Text] [Related]
20. Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Azzazene D; Al Thawadi H; Al Farsi H; Besbes S; Geyl C; Mirshahi S; Pardo J; Faussat AM; Jeannette S; Therwath A; Pujade-Lauraine E; Mirshahi M
Int J Oncol; 2013 Oct; 43(4):1011-8. PubMed ID: 23877403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
